Benefits of novel PET radiotracer expected to go beyond multiple sclerosis
Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence
DoD grant supports creation, validation of multidimensional field assessments
New episode of ‘Neuro Pathways’ podcast keeps you current on emerging insights
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First cases set the course for a full spectrum of intrauterine therapies
Newly discovered signaling loop is shown to be druggable
New episode of ‘Neuro Pathways’ podcast shares expert perspectives
New clinical trials size up an immunomodulator’s pleiotropic effects
Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition
Increasing the scope of care for headache patients
Advertisement
Advertisement